全球神经调控设备市场规模、份额、趋势及成长分析报告（2026-2034年）

预计神经调节设备市场将从 2025 年的 64.5 亿美元成长到 2034 年的 139.8 亿美元，2026 年至 2034 年的复合年增长率为 8.97%。

随着医疗机构采用先进技术治疗神经系统疾病，神经调控设备的市场也不断成长。这些设备，例如脊髓刺激设备、深部脑部刺激器和迷走神经刺激设备，可为慢性疼痛、运动障碍、癫痫和忧郁症疾病提供治疗性介入。神经系统疾病盛行率的不断上升以及人们对微创、标靶治疗日益增长的关注，正在推动这些设备在临床和居家医疗环境中的应用。

技术创新正在提高治疗的精准度和患者疗效。封闭回路型系统、植入式刺激器和无线连接技术实现了即时监测和自适应治疗调整。人工智慧驱动的演算法优化刺激参数，实现个人化治疗，而电池和材料的创新则增强了设备的耐用性和生物相容性。远端监测平台使临床医生能够追踪治疗进度并调整治疗方案，无需频繁往返医院。

预计未来成长将主要由慢性疼痛、精神疾病和復健等领域的广泛应用所推动。北美和欧洲凭藉其先进的医疗基础设施处于主导地位，而随着神经系统疾病诊疗服务的扩展，亚太地区的应用也不断推进。设备製造商、研究机构和临床中心之间的策略合作正在加速创新。结合以患者为中心的设计和最尖端科技的神经调控设备有望成为精准神经治疗的关键工具。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球神经调控设备市场：依产品划分

• 市场分析、洞察与预测
• 脊髓刺激设备
• 深部脑部刺激器
• 荐骨神经刺激器
• 迷走神经刺激设备
• 胃电刺激
• 其他的

第五章 全球神经调控设备市场：依应用领域划分

• 市场分析、洞察与预测
• 帕金森氏症
• 慢性疼痛
• 癫痫
• 偏头痛
• 尿失禁和粪便失禁
• 震颤
• 忧郁症
• 其他的

第六章 全球神经调控设备市场：依最终用途划分

• 市场分析、洞察与预测
• 医院和门诊手术中心（ASC）
• 诊所和物理治疗中心
• 其他的

第七章 全球神经调控设备市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corporation
  • Nexstim Plc
  • LivaNova Plc
  • Neuropace Inc
  • Nevro Corporation
  • ElectroCore Inc
  • Axonics Inc
  • Laborie Inc

The Neuromodulation Devices Market size is expected to reach USD 13.98 Billion in 2034 from USD 6.45 Billion (2025) growing at a CAGR of 8.97% during 2026-2034.

The neuromodulation devices market is growing as healthcare providers adopt advanced technologies for neurological disorder management. These devices, including spinal cord stimulators, deep brain stimulators, and vagus nerve stimulators, offer therapeutic interventions for chronic pain, movement disorders, epilepsy, and depression. Increasing prevalence of neurological diseases and emphasis on minimally invasive, targeted therapies are driving adoption across clinical and homecare settings.

Technological innovation is advancing treatment precision and patient outcomes. Closed-loop systems, implantable stimulators, and wireless connectivity allow real-time monitoring and adaptive therapy adjustments. AI-driven algorithms optimize stimulation parameters for personalized treatment, while battery and material innovations enhance device longevity and biocompatibility. Remote monitoring platforms enable clinicians to track progress and adjust therapy without frequent hospital visits.

Future growth is expected from expanding applications in chronic pain, psychiatric disorders, and rehabilitation. North America and Europe lead due to advanced healthcare infrastructure, while Asia-Pacific adoption is rising with expanding neurological care services. Strategic partnerships between device manufacturers, research institutions, and clinical centers are accelerating innovation. Neuromodulation devices are positioned to become essential tools in precision neurotherapeutics, combining patient-centric design with cutting-edge technology.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Gastric Electrical Stimulation
• Others

By Application

• Parkinson's Disease
• Chronic Pain
• Epilepsy
• Migraine
• Urinary & Faecal Incontinence
• Tremor
• Depression
• Others

By End-use

• Hospitals & Ambulatory Surgery Centers (ASC)
• Clinics & Physiotherapy Centers
• Others

COMPANIES PROFILED

• Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Nexstim plc, LivaNova plc, Neuropace Inc, Nevro Corporation, electroCore Inc, Axonics Inc, Laborie Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROMODULATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Spinal Cord Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Deep Brain Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Sacral Nerve Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Vagus Nerve Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Gastric Electrical Stimulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROMODULATION DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Parkinson's Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chronic Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Epilepsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Migraine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Urinary & Faecal Incontinence Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Tremor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Depression Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROMODULATION DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals & Ambulatory Surgery Centers (ASC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics & Physiotherapy Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEUROMODULATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEUROMODULATION DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 Medtronic Plc
  • 9.2.3 Boston Scientific Corporation
  • 9.2.4 Nexstim Plc
  • 9.2.5 LivaNova Plc
  • 9.2.6 Neuropace Inc
  • 9.2.7 Nevro Corporation
  • 9.2.8 ElectroCore Inc
  • 9.2.9 Axonics Inc
  • 9.2.10 Laborie Inc